However, since the palmitoylation of many targets is likely increased with Palm-B, targeting zDHHC13 is suggested to be a better option in preventing melanoma development; therefore, investigating mechanisms underlying its regulation may offer additional therapeutic strategies. This evidence concerns the gene ZDHHC13 and melanoma.